Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
Public ClinicalTrials.gov record NCT01120301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
NeuroThera® Efficacy and Safety Trial - 3 (NEST-3) A Double-blind, Randomized, Sham-controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Efficacy of Transcranial Laser Therapy With the NeuroThera® Laser System for the Treatment of Acute Ischemic Stroke Within 24 Hours of Stroke Onset
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this pivotal study is to demonstrate safety and efficacy of transcranial laser therapy (TLT) with the NeuroThera® Laser System in the treatment of subjects diagnosed with acute ischemic stroke. The initiation of the TLT procedure must be feasible for each subject between 4.5 and 24 hours of stroke onset.
Study identification
- NCT ID
- NCT01120301
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Sep 2012 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 15, 2013
Started 2010
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Birmingham | Birmingham | Alabama | 35294 | — |
| Sparks Regional Medical Center | Fort Smith | Arkansas | 72901 | — |
| Scripps Encinitas Hospital | Encinitas | California | 92024 | — |
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92658 | — |
| Stanford Stroke Center | Palo Alto | California | 94304 | — |
| Munroe Regional Medical Center | Ocala | Florida | 34474 | — |
| Gwinnett Medical Center | Duluth | Georgia | 30096 | — |
| Gwinnett Medical Center | Lawrenceville | Georgia | 30045 | — |
| Parkview Hospital | Fort Wayne | Indiana | 46805 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| UMass Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| Minneapolis Clinic of Neurology | Robbinsdale | Minnesota | 55422 | — |
| Saint Lukes Hospital | Kansas City | Missouri | 64111 | — |
| University of Washington St. Louis | St Louis | Missouri | 63110 | — |
| Mission Hospital/Mission Neurology Services | Asheville | North Carolina | 28801 | — |
| University of North Carolina Healthcare | Chapel Hill | North Carolina | 27514 | — |
| Guilford Neuro/The Moses H. Cone Memorial Hospital | Greensboro | North Carolina | 27401 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| Erlanger Health System | Chattanooga | Tennessee | 37403 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
| INOVA Hospital | Falls Church | Virginia | 22042 | — |
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 | — |
| Carilion Roanoke Memorial Hospital | Roanoke | Virginia | 24014 | — |
| Winchester Medical Center | Winchester | Virginia | 22601 | — |
| Harborview Medical Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01120301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 15, 2013 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01120301 live on ClinicalTrials.gov.